2000•PubMedRequires access

[Clinical significance of P-glycoprotein and CD34 expression of acute leukemia].

Lin Xm, Xie Zx, Zhu Pa

Open publisher page 0 citations

Abstract

The expression of P-glycoprotein(P-170) and CD34 was detected in the bone marrow mononuclear cells of 30 patients with acute leukemia by immunocytochemical technique using JSB-1 and Tük 3 monoclonal antibody. The results were that expression of P-170 and CD34 had no significant difference between acute nonlymphoblastic leukemia and acute lymphoblastic leukemia(P > 0.05). The clinical therapeutic effect was poor in P-170 or CD34 positive patients and had significant difference compared with those negative patients(P < 0.05). Judgments of therapeutic effect for acute leukemia can be improved by detecting the expression of P-170 and CD34 simultaneously.

About this research paper

What this paper is about

The expression of P-glycoprotein(P-170) and CD34 was detected in the bone marrow mononuclear cells of 30 patients with acute leukemia by immunocytochemical technique using JSB-1 and Tük 3 monoclonal antibody. The results were that expression of P-170 and CD34 had no significant difference between acute nonlymphoblastic leukemia and acute lymphoblastic leukemia(P > 0.05). The clinical therapeutic effect was poor in P-170 or CD34 positive patients and had significant difference compared with those negative patients(P < 0.05). Judgments of therapeutic effect for acute leukemia can be improved by detecting the expression of P-170 and CD34 simultaneously.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The expression of P-glycoprotein(P-170) and CD34 was detected in the bone marrow mononuclear cells of 30 patients with acute leukemia by immunocytochemical technique using JSB-1 and Tük 3 monoclonal antibody. The results were that expression of P-170 and CD34 had no significant difference between acute nonlymphoblastic leukemia and acute lymphoblastic leukemia(P > 0.05). The clinical therapeutic effect was poor in P-170 or CD34 positive patients and had significant difference compared with those negative patients(P < 0.05). Judgments of therapeutic effect for acute leukemia can be improved by detecting the expression of P-170 and CD34 simultaneously.

Key concepts: CD34, Acute leukemia, Medicine, Leukemia, Peripheral blood mononuclear cell, Bone marrow, Significant difference, Monoclonal antibody

Related papers

Back to paper searchBrowse research topicsOriginal source
[Clinical significance of P-glycoprotein and CD34 expression of acute leukemia]. — Research Paper | ScholarLens